XAIR News and Press, Beyond Air Inc. From 08/11/22

Initiated U.S. commercial launch of LungFit® PH for the treatment of term and near-term neonates with hypoxic respiratory failure, which received FDA approval on June 28, 2022 Will present data from the pilot study of at-home LungFit® GO for nontuberculous mycobacter...

GARDEN CITY, N.Y., July 27, 2022 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hyp...

Gaining for the fifth straight session on Wednesday, the shares of the medical device company Beyond Air ( NASDAQ: XAIR ) approached the highest level since December after the company insiders disclosed more than $2.3M of insider transactions. According to SEC filings, mem...

Analyst comments provided a key catalyst in Wednesday's midday trading. Both Carnival ( NYSE: CCL ) and Upstart ( UPST ) dropped on negative notes from Morgan Stanley. Meanwhile, earnings news prompted a notable move in McCormick ( MKC ). Shares lost ground following a d...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: rafapress / Shutterstock.com Upstart (NASDAQ: UPST ) stock is taking a beating on Wednesday after Morgan Stanley analyst James Faucette hit the shares with a downgrade . That downgrade saw Faucette dr...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Jonathan Weiss / Shutterstock.com Bed Bath & Beyond (NASDAQ: BBBY ) stock is falling on Wednesday following the release of its fiscal first-quarter earnings report and news its CEO is departing. Le...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Beyond Air (NASDAQ: XAIR ) stock jumped nearly 20% in early trading and is trending on many social media websites. The company’s LungFit PH device, which treats some of the newborns who have respiratory fai...

Beyond Air, Inc. (XAIR) Q4 2022 Earnings Conference Call June 28, 2022 16:30 ET Company Participants Corey Davis - Investor Relations Steve Lisi - Chairman and Chief Executive Officer Duncan Fatkin - Chief Commercial Officer Douglas Larson - Chief Financial Officer Conference Call Participant...

Beyond Air (NASDAQ:XAIR) stock gained after hours on Tuesday after the company said the U.S. FDA had approved its nitric oxide generator and delivery system LungFit PH to treat infants with hypoxic respiratory failure. XAIR stock added ~25% to $7.25. XAIR said this was the firs...

Beyond Air press release (NASDAQ:XAIR): FY GAAP EPS of -$1.68 misses by $0.47. As of March 31, 2022, the Company had cash and cash equivalents of $80.2 million. Shares +35.81%. For further details see: Beyond Air GAAP EPS of -$1.68 misses by $0.47